We introduce ourselves as Goldshield Plc. U.K., a young dynamic and emerging pharmaceuticals company marketing ethical prescription products within the U.K, European and other international markets. We currently have presence in more than 50 countries throughout the world. The majority of the turnover is within UK and strategies are in place to grow established business within other countries using both existing and new products.
With sales of over ₤ 80 million, we are operating in various countries in Europe, Asia, Australia and Africa. Some of our well known international brands are Stelazine, Ecotrin and Flexeze. We also market speciality products like Dobutamine,
Europe.Bloombiz.com Tip: We always strongly recommend our members to strictly follow the traditional methods and rules of international trading before going into any deal with any party met over the internet. Such as getting prior company confirmation by phone, fax or by mail besides necessary cross checks done through the related local bodies like banks, chambers of commerce, related trade associations, etc. especially before realizing any money transaction.
Statistics: Companies: 640,800+, Trade Leads: 160,200+, Products: 104,100+, Contacts / Replies: 8,284,300+Privacy Policy Important Notice! TradeHolding.com B2B Network does not provide an escrow service! Any member who asks you to pay for their products by Western Union to an agent of "TradeHolding.com B2B Network" is fraud and should be immediately reported to us. Do not pay anything to any member who states your money will be added to TradeHolding.com safety deposit account!
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and Europe.Bloombiz.com and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.